Lista de obras -

A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer

artículo científico publicado en 2020

A new model for reimbursing genome-based cancer care

artículo científico publicado en 2014

AACR Cancer Progress Report 2014

artículo científico publicado en 2014

Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer

artículo científico publicado en 2015

Aspirin, clopidogrel, or both for secondary prevention of coronary disease

artículo científico publicado en 2003

Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients

artículo científico publicado en 2008

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research

artículo científico publicado en 2012

Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective

artículo científico publicado en 2013

Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis

artículo científico publicado en 2012

Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy

artículo científico publicado en 2011

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2008

Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects

artículo científico publicado en 2013

Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population

artículo científico publicado en 2011

Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report

artículo científico publicado en 2015

Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer

artículo científico publicado en 2014

Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer

artículo científico publicado en 2014

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens

artículo científico publicado en 2014

Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences

artículo científico publicado en 2013

Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis

artículo científico publicado en 2013

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer

artículo científico publicado en 2005

Localized Prostate Cancer: Quality of Life Meets Whitmore's Legacy

artículo científico publicado en 2004

Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial

artículo científico publicado en 2016

Measuring costs: administrative claims data, clinical trials, and beyond.

artículo científico publicado en 2002

New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder

artículo científico publicado en 2012

Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting

artículo científico publicado en 2013

Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions

scientific article published on 20 October 2010

Preliminary treatment considerations among men with newly diagnosed prostate cancer

artículo científico publicado en 2010

Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer

artículo científico publicado en 2011

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability ⬇️

artículo científico publicado en 2004

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor

artículo científico publicado en 2010

Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer

artículo científico publicado en 2014

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials

article

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

artículo científico publicado en 2018

Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis

artículo científico publicado en 2012

Lista de obras de

A comparison of general, genitourinary, bowel, and sexual quality of life among long term survivors of prostate, bladder, colorectal, and lung cancer

A new model for reimbursing genome-based cancer care

AACR Cancer Progress Report 2014

Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer

Aspirin, clopidogrel, or both for secondary prevention of coronary disease

Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research

Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective

Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis

Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects

Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population

Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report

Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer

Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens

Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences

Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer

Localized Prostate Cancer: Quality of Life Meets Whitmore's Legacy

Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial

Measuring costs: administrative claims data, clinical trials, and beyond.

New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder

Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting

Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions

Preliminary treatment considerations among men with newly diagnosed prostate cancer

Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability ⬇️

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor

Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis